NCT06084533View on ClinicalTrials.gov

CS1P1 PET Studies of Neuroinflammation in Parkinson Disease

Enrolling by invitationOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

February 1, 2029

Study Completion Date

February 28, 2029

Conditions
Parkinson Disease
Interventions
DRUG

[11C]-CS1P1

Participants will receive a single intravenous bolus injection of 10.0 - 20.0 milliCurie (mCi) of the investigational radiotracer \[11C\]-CS1P1. Participants will then undergo a \[11C\]-CS1P1 PET scan.

Trial Locations (1)

63105

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER